ClinicalTrials.Veeva

Menu

Use of the Thrombectomy Device ReVive™ SE in the Acute Treatment of Stroke (REVIVE SE)

Civil Hospices of Lyon logo

Civil Hospices of Lyon

Status

Completed

Conditions

Stroke

Treatments

Device: REVIVETM SE thrombectomy

Study type

Interventional

Funder types

Other

Identifiers

NCT02971826
2016-A01470-51 (Other Identifier)
69HCL16_0571

Details and patient eligibility

About

The last marketed thrombectomy devices, named stentretriever, permit a better and faster recanalization in patient with a stroke. The REVIVETM SE is a device designed to restore the brain perfusion in patient with an intracranial artery occlusion. The REVIVETM Se device is not widely use in Europe and in France. The objective of this study is to assess the interest of using this device in the standard care of ischemic stroke in the radiology unit of the hospital Pierre Wertheimer, Lyon. The medical care will not be modified but data will be collected in order to determine whether or not this device is useful for the practice of the radiology unit.

Enrollment

1 patient

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient with an ischemic stroke detected by Computed Tomography (CT) or Magnetic Resonance Image (MRI)
  • Large proximal arterial occlusion : M1 segment of the Middle cerebral artery (MCA), Internal Carotid Artery (ICA) or Basilar Artery (BA)
  • Last known well (without neurological symptoms) ≤ 8 hours of treatment initiation
  • Score NIHSS ≥4
  • Eligibility on an endovascular procedure using REVIVETM SE device
  • No opposition of the patient to participate at the study

Exclusion criteria

  • Diagnostic cerebral imaging impossible
  • Distal occlusion
  • Tortuous vessel or other specificity preventing the access of device
  • Vessel diameter < 1.5 mm
  • Known hypersensibility or allergy to nitinol
  • Subjects not covered by or having the right to social security
  • Deprivation of civil rights (guardianship, safeguard justice)

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

1 participants in 1 patient group

Thrombectomy using the REVIVETM SE device
Experimental group
Description:
Thrombectomy using the REVIVETM SE device in patient with an ischemic stroke
Treatment:
Device: REVIVETM SE thrombectomy

Trial contacts and locations

1

Loading...

Central trial contact

Claire Jossan; Françis TURJMAN, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems